Announcements Trials
Browse Landscape

Phase

Phase 3 4

Status

Completed 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 3

Conditions

Uterine Cervical Neoplasms 4Condylomata Acuminata 4Papillomavirus Infections 3Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Dysplasia 1Cancer Survivor 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 7Vaccines, Synthetic 4Imiquimod 2berdazimer sodium 1VP-102 1Therapies, Investigational 1Surgical Procedures, Operative 1Papillomavirus Vaccines 1Human Papillomavirus Recombinant Vaccine nonavalent 1Hepatitis B Vaccines 1Gels 1Ethanol 1Cantharidin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Has results × Condylomata Acuminata × Vaccines, Synthetic × Clear all
NCT00092534 2025-08-01

FUTURE II

Merck Sharp & Dohme LLC

Phase 3 Completed
12,167 enrolled 23 charts
Gynecologic

Uterine Cervical Neoplasms, Condylomata Acuminata

NCT01245764 2018-11-14

GARDASILâ„¢ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046)

Merck Sharp & Dohme LLC

Phase 3 Completed
250 enrolled 20 charts
Gynecologic

Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

NCT00090285 2018-08-23

V501-020

Merck Sharp & Dohme LLC

Phase 3 Completed
4,065 enrolled 27 charts

Condylomata Acuminata

NCT00092495 2015-01-13

Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)

Merck Sharp & Dohme LLC

Phase 3 Completed
3,055 enrolled 25 charts
Gynecologic

Uterine Cervical Neoplasms, Condylomata Acuminata

Data powered by HemOnc (CC BY 4.0) Colophon âš¡